Pursuant to Art. 19 Market Abuse Regulation (EU/596/2014) ("MAR") members of the management board and supervisory board of Biotest AG, as well as any other persons performing executive functions with Biotest AG, are obliged to notify Biotest AG and the German Federal Financial Supervisory Authority (BaFin) of own transactions in Biotest shares, or financial instruments based on them. The notification duty also applies to individuals and legal entities closely associated with such persons.
In addition to all ways of publication required by law Biotest AG will disclose details of any such manager's transactions which occurred within the last twelve months on this websitewithout undue delay and will transmit to the German Federal Financial Supervisory Authority evidence of such disclosure.